Table 2.

Inhibitory receptor superfamily down-regulate natural killer cell apoptosis induced by specific soluble HLA class I alleles

NilSpecific sHLA-ISpecific sHLA-I + specific anti-IRS mAbIrrelevant sHLA-I + specific anti-IRS mAb
Bulk NK-3 KIR2D+(CD158b+/GL183+35 70 37 
Clone MZ25.4 KIR2D+(CD158b+/GL183+25 40 28 
Bulk NK-4 (CD94+KIR2D37 60 40  
Clone RB50.3 (CD94+ KIR2D40 65 37 
NilSpecific sHLA-ISpecific sHLA-I + specific anti-IRS mAbIrrelevant sHLA-I + specific anti-IRS mAb
Bulk NK-3 KIR2D+(CD158b+/GL183+35 70 37 
Clone MZ25.4 KIR2D+(CD158b+/GL183+25 40 28 
Bulk NK-4 (CD94+KIR2D37 60 40  
Clone RB50.3 (CD94+ KIR2D40 65 37 

A total of 5 × 104 cells (from natural killer [NK]-3 KIR2D+ bulk population 95% CD8+, or clone MZ25.4 KIR2D+ CD8bright, or NK-4 bulk population 90% CD8+CD94+ KIR2D, or clone RB50.3 CD94+KIR2DCD8bright) were cultured for 48 hours in medium alone (nil) or with 4 μg/mL specific soluble HLA class I (sHLA-I; HLA-Cw3 for KIR2D+[CD158b+/GL183+] or HLA-G1 for CD94+KIR2D NK cells) or irrelevant sHLA-I (sHLA-A2 allele), either in the absence or after pretreatment with anti-inhibitory receptor superfamily (IRS) monoclonal antibody (mAb; GL183 for KIR2D+ or anti-CD94 for CD94+KIR2D NK cells). Apoptosis was evaluated by staining with fluorescein isothiocyanate–annexin V. Samples were run on a FACSort (Becton Dickinson), and results are expressed as the percentage of annexin V+ PI cells.

Close Modal

or Create an Account

Close Modal
Close Modal